LABU Holdings Information

LABU is an equity ETF with a total of 145 individual holdings.

Total Holdings

145

Top 10 Percentage

100.20%

Asset Class

Equity

ETF Category

Trading--Leveraged Equity

Assets

749.21M

PE Ratio

n/a

Sector Allocation

No.	Symbol	Name	% Weight	Shares
1	n/a	S&P Biotechnology Select Industry Index Swap	45.20%	229,711
2	n/a	Dreyfus Govt Cash Man Ins	22.82%	183,448,183
3	n/a	Goldman Sachs Sterling FixInc Port Inc	13.05%	104,886,157
4	n/a	Goldman Sachs Fin Gov 465 Institut	10.79%	86,721,150
5	n/a	Dreyfus Trsry Securities Cash Mgmt	3.44%	27,630,390
6	CRSP	CRISPR Therapeutics AG	1.12%	131,930
7	INSM	Insmed Incorporated	0.96%	47,163
8	UTHR	United Therapeutics Corporation	0.95%	17,362
9	IONS	Ionis Pharmaceuticals, Inc.	0.94%	107,543
10	MRNA	Moderna, Inc.	0.94%	283,128
11	RVMD	Revolution Medicines, Inc.	0.93%	153,771
12	ABBV	AbbVie Inc.	0.93%	32,523
13	EXAS	Exact Sciences Corporation	0.93%	125,668
14	BBIO	BridgeBio Pharma, Inc.	0.90%	129,961
15	RNA	Avidity Biosciences, Inc.	0.90%	148,337
16	AMGN	Amgen Inc.	0.90%	24,713
17	VRTX	Vertex Pharmaceuticals Incorporated	0.90%	17,713
18	NTRA	Natera, Inc.	0.88%	40,539
19	GILD	Gilead Sciences, Inc.	0.88%	59,718
20	EXEL	Exelixis, Inc.	0.87%	182,569
21	BIIB	Biogen Inc.	0.87%	48,263
22	REGN	Regeneron Pharmaceuticals, Inc.	0.86%	12,381
23	MDGL	Madrigal Pharmaceuticals, Inc.	0.85%	16,003
24	ALNY	Alnylam Pharmaceuticals, Inc.	0.85%	14,667
25	INCY	Incyte Corporation	0.84%	79,804

Showing 25 of 145 holdings

Subscribe to see the full list

As of Oct 13, 2025